造血干细胞移植后性功能多模式干预的随机对照试验结果
A multimodal approach to sexual function after allogeneic hematopoietic stem cell transplantation: a randomized controlled trial
该项随机对照试验评估了针对造血干细胞移植幸存者的多模式性功能干预方案。研究比较了多模式干预组与强化常规护理组,并采用FSFI和IIEF等量表评估患者的性功能变化。
References
Pulte D, Jansen L, Castro FA, Brenner H. Changes in the survival of older patients with hematologic malignancies in the early 21st century. Cancer. 2016;122:2031–40.
Pulte D, Redaniel MT, Jansen L, Brenner H, Jeffreys M. Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups. Haematologica. 2013;98:222–9.
Sant M, Minicozzi P, Mounier M, Anderson LA, Brenner H, Holleczek B, et al. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. Lancet Oncol. 2014;15:931–42.
Bhatia S, Dai C, Landier W, Hageman L, Wu J, Schlichting E, et al. Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study Report. JAMA Oncol. 2021;7:1626–34.
Syrjala KL, Schoemans H, Yi JC, Langer SL, Mukherjee A, Onstad L, et al. Sexual Functioning in Long-Term Survivors of Hematopoietic Cell Transplantation. Transpl Cell Ther. 2021;27:80.e1–80.e12.
Battiwalla M, Hashmi S, Majhail N, Pavletic S, Savani BN, Shelburne N. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes, Biology of blood and marrow transplantation : journal of the American Society for Blood and. Marrow Transplant. 2017;23:6–9.
Bevans M, El-Jawahri A, Tierney DK, Wiener L, Wood WA, Hoodin F, et al. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report, Biology of blood and marrow transplantation : journal of the American Society for Blood and. Marrow Transplant. 2017;23:538–51.
Gjærde LK, Eeltink C, Stringer J, Mooyaart J, Bosman P, Kenyon M, et al. Sexual function of adult long-term survivors and their partners after allogeneic hematopoietic cell transplantation in Europe (S-FAST): a study from the Transplant Complications Working Party and Nurses Group of the EBMT. Bone Marrow Transplant. 2023;58:195–202.
Alsuliman T, Jondreville L, Baylet C, Dann MP, De Bentzmann N, Fontoura ML et al. Sexual and Emotional Health after Allogeneic Hematopoietic Cell Transplantation: A Comprehensive Review and Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC). J Clin Med. 2022;11:1196.
Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, et al. Survivorship: sexual dysfunction (female), version 1.2019. J Natl Compr Cancer Netw. 2014;12:184–92.
Noerskov KH, Schjodt I, Syrjala KL, Jarden M. Sexual function 1-year after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2016;51:833–40.
Shanis D, Yang L, Bevans M, Scrivani C, Merideth MA, Childs RW, et al. Genital Graft-Versus-Host-Disease Predicts Decreased Sexual Function in Female Survivors of Allogeneic Hematopoietic Stem Cell Transplant. Transpl Cell Ther. 2025;31:834.e1–834.e11.
Wilk Goldsher Y, Cohen Sacher B, Cohen M, Yeshurun M, Sabah G, Eitan R, et al. Genital graft versus host disease in women after allogeneic hematopoietic stem cell transplantation - a single center experience. Ann Hematol. 2025;104:773–9.
Smith Knutsson E, Bjork Y, Broman AK, Helstrom L, Nicklasson M, Brune M, et al. A prospective study of female genital chronic graft-versus-host disease symptoms, signs, diagnosis and treatment. Acta Obstet Gynecol Scand. 2018;97:1122–9.
Lee YJ, Kim JS, Jo JC, Kim Y, Im HS, Kim H, et al. Risk factors of menopause after allogeneic hematopoietic cell transplantation in premenopausal adult women. Eur J Haematol. 2023;111:449–57.
Preston M, Richards A. Vulvar and Vaginal Graft Versus Host Disease After Allogeneic Stem Cell Transplant-A Systematic Review. J Low Genit Trac Dis. 2023;27:266–74.
Machado AMN, Hamerschlak N, Rodrigues M, Piccinato CA, Podgaec S, Mauad LMQ. Female genital tract chronic graft-versus-host disease: A narrative review. Hematol Transfus Cell Ther. 2019;41:69–75.
Wdowiarz K, Reinholz-Jaskolska M, Radowicka M, Wielgos M, Pietrzak B. Gynecological complications and treatment strategies in patients after hematopoietic stem cell transplantation. Ginekol Pol. 2025;96:399–404.
Mueller SM, Haeusermann P, Rovo A, Halter JP, Passweg J, Itin P, et al. Genital chronic GVHD in men after hematopoietic stem cell transplantation: a single-center cross-sectional analysis of 155 patients. Biol Blood Marrow Transplant. 2013;19:1574–80.
Andreini A, Zampieri N, Costantini C, Malerba G, Bruno C, Salvagno G, et al. Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience. Leuk Lymphoma. 2018;59:2719–22.
Dyer G, Gilroy N, Bradford J, Brice L, Kabir M, Greenwood M, et al. A survey of fertility and sexual health following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia. Br J Haematol. 2016;172:592–601.
Wong FL, Francisco L, Togawa K, Kim H, Bosworth A, Atencio L, et al. Longitudinal trajectory of sexual functioning after hematopoietic cell transplantation: impact of chronic graft-versus-host disease and total body irradiation. Blood. 2013;122:3973–81.
Martínez-Maestre M, Castelo-Branco C, Calderón AM, Espigado I, Pérez-Simón JA, González-Cejudo C. Genital chronic graft-versus-host disease: an unmet need that requires trained gynecologists. Climacteric. 2024;27:275–81.
Phelan R, Im A, Hunter RL, Inamoto Y, Lupo-Stanghellini MT, Rovo A, et al. Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. Transpl Cell Ther. 2022;28:335.e1–335.e17.
Lev-Sagie A, Adar-Walling E, Gumer A, Grisariu S, Avni B. Management and long-term consequences of genital graft versus host disease following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2020;55:2234–43.
Norskov KH, Schmidt M, Jarden M. Patients’ experience of sexuality 1-year after allogeneic Haematopoietic Stem Cell Transplantation. Eur J Oncol Nurs. 2015;19:419–26.
Alsuliman T, Alasadi L, Polomeni A, Capes A, Peric Z, Linke A, et al. Sexual health-related psychological and emotional life after allogeneic haematopoietic stem-cell transplantation. Lancet Haematol. 2024;11:e780–e791.
Lahijani S, Rueda-Lara M, McAndrew N, Nelson AM, Guo M, Knight JM, et al. A Biobehavioral Perspective on Caring for Allogeneic Hematopoietic Stem Cell Transplant Survivors with Graft-Versus-Host Disease. Transplant Cell Ther. 2024;30:S493–S512.
Yi JC, Syrjala KL. Sexuality after hematopoietic stem cell transplantation. Cancer J. 2009;15:57–64.
Sanft T, Day A, Ansbaugh S, Armenian S, Baker KS, Ballinger T, et al. NCCN Guidelines® Insights: Survivorship, Version 1.2023. J Natl Compr Cancer Netw. 2023;21:792–803.
Nørskov KH, Schjoedt I, Tolver A, Jarden M. Sexual health in patients with malignant hematological disease: a Danish cross-sectional study. Sex Med. 2024;12:qfae053.
A El-Jawahri, JB Reese, L Traeger, D Dizon, C Cutler, S Bober, et al. A Digital Intervention to Address Sexual Health in Hematopoietic Stem Cell Transplant Survivors. J Natl Compr Canc Netw. 2025;23:e247076.
NH Markovitz, L Traeger, J Vanderklish, N Horick, R Newcomb, IS Larizza, et al. Sexual Health in Hematopoietic Stem Cell Transplantation Survivors. J Natl Compr Canc Netw. 2025;23:e257019.
El-Jawahri A, Fishman SR, Vanderklish J, Dizon DS, Pensak N, Traeger L, et al. Pilot study of a multimodal intervention to enhance sexual function in survivors of hematopoietic stem cell transplantation. Cancer. 2018;124:2438–46.
Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2015;21:389–401.e1.
Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191–208.
Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31:1–20.
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–30.
Greimel E, Nagele E, Lanceley A, Oberguggenberger AS, Nordin A, Kuljanic K, et al. Psychometric validation of the European Organisation for Research and Treatment of Cancer-Quality of Life Questionnaire Sexual Health (EORTC QLQ-SH22). Eur J Cancer. 2021;154:235–45.
Derogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J. The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther. 2002;28:317–30.
Santos-Iglesias P, Mohamed B, Danko A, Walker LM. Psychometric Validation of the Female Sexual Distress Scale in Male Samples. Arch Sex Behav. 2018;47:1733–43.
DeRogatis L, Clayton A, Lewis-D’Agostino D, Wunderlich G, Fu Y. Validation of the Female Sexual Distress Scale-Revised for Assessing Distress in Women with Hypoactive Sexual Desire Disorder. J Sex Med. 2008;5:357–64.
Althof S, Derogatis LR, Greenberg S, Clayton AH, Jordan R, Lucas J, et al. Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide. J Sex Med. 2019;16:1226–35.
Campbell JD, Trock BJ, Oppenheim AR, Anusionwu I, Gor RA, Burnett AL. Meta-analysis of randomized controlled trials that assess the efficacy of low-intensity shockwave therapy for the treatment of erectile dysfunction. Ther Adv Urol. 2019;11:1756287219838364.
Madsen CH, Graugaard C, Dalton SO, Andersson M, Bidstrup PE, Frisch M. Sexual health among Danish cancer survivors and individuals with no history of cancer: Baseline findings from the nationwide Project SEXUS cohort study. Cancer. 2025;131:e70074.
Michael S, Skaczkowski G, Wilson C. Sexual satisfaction and sexual distress after cancer: The role of body image disruption, self-compassion, sexual pain and relationship satisfaction. Psycho Oncol. 2021;30:1902–9.
Frey Tirri B, Häusermann P, Bertz H, Greinix H, Lawitschka A, Schwarze CP, et al. Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD. Bone Marrow Transpl. 2015;50:3–9.
Hamilton BK, Goje O, Savani BN, Majhail NS, Stratton P. Clinical management of genital chronic GvHD. Bone Marrow Transpl. 2017;52:803–10.
Carney LM, Schnur JB, Morgan O, Hyun C, Magin ZE, Martin L, et al. Psychosocial interventions to improve sexual functioning in women with cancer: a systematic review of randomized controlled trials. Sex Med Rev. 2024;12:142–53.
Candy B, Jones L, Vickerstaff V, Tookman A, King M. Interventions for sexual dysfunction following treatments for cancer in women. Cochrane Database Syst Rev. 2016;2:Cd005540.
Arring N, Barton DL, Reese JB. Clinical Practice Strategies to Address Sexual Health in Female Cancer Survivors. J Clin Oncol. 2023;41:4927–36.
Günzler C, Berner MM. Efficacy of Psychosocial Interventions in Men and Women with Sexual Dysfunctions—A Systematic Review of Controlled Clinical Trials. J Sex Med. 2012;9:3108–25.
The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27:976–92.
Tierney DK, Palesh O, Johnston L. Sexuality, Menopausal Symptoms, and Quality of Life in Premenopausal Women in the First Year Following Hematopoietic Cell Transplantation. Oncol Nurs Forum. 2015;42:488–97.
Schubach K, Niyonsenga T, Turner M, Paterson C. Experiences of sexual well-being interventions in males affected by genitourinary cancers and their partners: an integrative systematic review. Support Care Cancer. 2023;31:265.
Pizzol D, Xiao T, Smith L, Sánchez GFL, Garolla A, Parris C, et al. Prevalence of erectile dysfunction in male survivors of cancer: a systematic review and meta-analysis of cross-sectional studies. Br J Gen Pr. 2021;71:e372–e380.
El-Jawahri A, Traeger L, Reese JB, Dizon D, Bober SL, Greer JA, et al. A multimodal sexual dysfunction intervention versus enhanced usual care for survivors of haematopoietic stem-cell transplantation: a single-centre, open-label, randomised clinical trial. Lancet Haematol. 2025;12:e611–e620.
Yang P, Zhang L, Tian X. Application of stepped care model in cancer patients: a scoping review. Support Care Cancer. 2024;33:34.
Abdalla T, Singh GK, Pourali Roudbaneh S, Serwaa D, Peate M. Stepped-care models for cancer symptom management: a systematic review of efficacy and cost-effectiveness. J Natl Cancer Inst. 2025;118:26–48.
American Society of Hematology. Choosing Wisely: Five Things Physicians and Patients Should Question. 2021. https://www.hematology.org/education/clinicians/guidelines-and-quality-care/choosing-wisely.
Corbacioglu, S, Sureda A, Greco R, editors. Chapter 22: Short- and Long-Term Controls After HCT. In: The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies. 2024. https://www.ncbi.nlm.nih.gov/books/NBK608290/.
Müskens J, Kool RB, van Dulmen SA, Westert GP. Overuse of diagnostic testing in healthcare: a systematic review. BMJ Qual Saf. 2022;31:54–63.
Rotz SJ, Bhatt NS, Hamilton BK, Duncan C, Aljurf M, Atsuta Y, et al. International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update. Bone Marrow Transplant. 2024;59:717–41.
来源:Nature 健康护理主题 · nature.com